New Wegovy Pill Sparks Hype — and Serious Warnings From Doctors

New Wegovy pill sparks hype — and serious warnings from doctors

Doctors call Wegovy’s new weight loss pill a game changer in the fight against obesity, but some experts are urging patients to be cautious. Just weeks after hitting the market, nearly 200,000 people are already taking the Wegovy pill, according to the company. While the pill offers convenience — and a lower price point than injectable semaglutides — its rapid rise in popularity has some doctors urging caution. “The efficacy is about the same. I…

GLP-1 weight-loss pill market surge to reshape US retail food and beverage demand, says GlobalData

Discover what's happening in retail today, Retail Times publishes international & UK retail news covering products, data, tech, packaging, people, research, comment and much more. In the GLP-1 weight management market, manufacturers are now launching oral drugs. Novo Nordisk announced the launch of the first GLP-1 drug (Wegovy) in a pill format last month. Eli Lilly & Co is in the process of launching its own GLP-1 pill, orforglipron post FDA ap…

Dippin’ Dot parent says MAHA, GLP-1 trends aren’t melting demand for indulgent treats

J&J Snack Foods’ CEO said the Icee owner is benefiting from a close association with experiences such as movies, theme parks and sporting events.